Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10108	Companies
207161	Keywords
137291	Articles
109798	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 02/17/2025 at 08:05, 1 year 1 month ago

EQS-Adhoc: Formycon announces decision on Phase III trial with FYB206 and provides update on potential need to adjust the valuation of FYB202 and FYB201
Formycon terminates Phase III trial for FYB206 after FDA feedback, anticipates valuation adjustments for FYB202 & FYB201 due to price discounts

FDA Feedback Valuation Adjustments Formycon FYB206 Price Discounts
BRIEF

published on 02/05/2025 at 06:35, 1 year 1 month ago

Lotus Pharmaceutical Partners with Formycon to Commercialize Eylea® Biosimilar in Asia-Pacific

Lotus Pharmaceutical Eylea® Biosimilar Asia-Pacific Commercialization FDA And EU Approval Retinal Disease Treatment
BRIEF

published on 02/05/2025 at 06:35, 1 year 1 month ago

Lotus Pharmaceutical s'associe à Formycon pour commercialiser le biosimilaire Eylea® en Asie-Pacifique

Lotus Pharmaceutique Biosimilaire Eylea® Commercialisation En Asie-Pacifique Approbation De La FDA Et De L'UE Traitement Des Maladies De La Rétine
PRESS RELEASE

published on 02/05/2025 at 06:30, 1 year 1 month ago

Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Formycon AG announces strategic partnership with Lotus Pharmaceutical for commercialization of Eylea biosimilar FYB203/AHZANTIVE in Asia-Pacific region

Formycon AG Asia-Pacific Eylea Biosimilar FYB203/AHZANTIVE Lotus Pharmaceutical
BRIEF

published on 01/20/2025 at 06:35, 1 year 2 months ago

Formycon Secures EU Approval for Biosimilar FYB203

Formycon AG EU Approval Teva Pharmaceuticals Aflibercept Biosimilar FYB203
BRIEF

published on 01/20/2025 at 06:35, 1 year 2 months ago

Formycon obtient l'approbation de l'UE pour le biosimilaire FYB203

Formycon AG Teva Pharmaceuticals Aflibercept Homologation UE Biosimilaire FYB203
PRESS RELEASE

published on 01/20/2025 at 06:30, 1 year 2 months ago

Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama®
Formycon receives EU approval for biosimilar FYB203 (aflibercept) to Eylea®, brands AHZANTIVE® and Baiama® for nAMD and retinal diseases. Teva to market AHZANTIVE® in Europe

Biosimilar Formycon EU Approval AHZANTIVE Baiama
BRIEF

published on 01/15/2025 at 06:35, 1 year 2 months ago

MHRA Grants Approval for Formycon and Fresenius Kabi's Otulfi®

Formycon Fresenius Kabi Ustekinumab Biosimilar Approval Otulfi® Launch
BRIEF

published on 01/15/2025 at 06:35, 1 year 2 months ago

La MHRA accorde son approbation à Formycon et à Otulfi® de Fresenius Kabi

Formycon Fresenius Kabi Ustekinumab Approbation Des Biosimilaires Lancement D'Otulfi®
PRESS RELEASE

published on 01/15/2025 at 06:30, 1 year 2 months ago

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi®, a biosimilar to Stelara®, for various inflammatory diseases. Global biosimilar approval news

Biosimilar Formycon Fresenius Kabi FYB202 MHRA Approval

Accesswire

Published on 03/28/2026 at 01:00, 1 day 3 hours ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 3 hours ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 day 3 hours ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 5 hours ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 day 5 hours ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 18 hours 9 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 19 hours 17 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 2 hours ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 6 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 day 6 hours ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 21 hours 14 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 9 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 9 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 9 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 9 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE